Rhumbline Advisers Grows Stock Holdings in Candel Therapeutics, Inc. (NASDAQ:CADL)
Rhumbline Advisers boosted its position in Candel Therapeutics, Inc. (NASDAQ:CADL – Free Report) by 17.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 26,272 shares of the company’s stock after acquiring an additional 3,817 shares during the period. Rhumbline Advisers’ holdings in Candel Therapeutics were worth $228,000 […]
Rhumbline Advisers boosted its position in Candel Therapeutics, Inc. (NASDAQ:CADL – Free Report) by 17.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 26,272 shares of the company’s stock after acquiring an additional 3,817 shares during the period. Rhumbline Advisers’ holdings in Candel Therapeutics were worth $228,000 […]
